RADIOGRAPHIC PROGRESSION-FREE SURVIVAL (RPFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN CHEMOTHERAPY-NAIVE METASTATIC CASTRATIONRESISTANT PROSTATE CANCER (MCRPC): A CORRELATION META-ANALYSIS

被引：0
|
作者：
Leung, L. [1 ]
Patel, M. [2 ]
Teitsson, S. [3 ]
Hofer, K. [1 ]
Qian, A. [1 ]
Kurt, M. [4 ]
机构：
[1] Evidinno Outcomes Res Inc, Vancouver, BC, Canada
[2] Bristol Myers Squibb, Lawrenceville, NJ USA
[3] Bristol Myers Squibb, Uxbridge, Middx, England
[4] Bristol Myers Squibb, Princeton, NJ USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO55
引用
收藏
页码：S28 / S28
页数：1
相关论文
共 50 条
  • [21] Progression-Free Survival as a Surrogate for Overall Survival in Advanced/Recurrent Gastric Cancer Trials: A Meta-Analysis
    Paoletti, Xavier
    Oba, Koji
    Bang, Yung-Jue
    Bleiberg, Harry
    Boku, Narikazu
    Bouche, Olivier
    Catalano, Paul
    Fuse, Nozomu
    Michiels, Stefan
    Moehler, Markus
    Morita, Satoshi
    Ohashi, Yasuo
    Ohtsu, Atsushi
    Roth, Arnaud
    Rougier, Philippe
    Sakamoto, Junichi
    Sargent, Daniel
    Sasako, Mitsuru
    Shitara, Kohei
    Thuss-Patience, Peter
    Van Cutsem, Eric
    Burzykowski, Tomasz
    Buyse, Marc
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2013, 105 (21): : 1667 - 1670
  • [22] A meta-analysis of randomized, controlled trials in metastatic melanoma establishes progression-free survival as a surrogate for overall survival
    Flaherty, K. T.
    Lee, S. J.
    Dummer, R.
    Hauschild, A.
    Hennig, M.
    Long, G. V.
    Lorigan, P.
    Robert, C.
    Schadendorf, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S856 - S856
  • [23] Progression-free survival as a surrogate endpoint of overall survival in advanced biliary tract cancer: A meta-analysis of randomized trials and individual-patient level correlation
    Fabregat Franco, Carles
    Castet, Florian
    La Casta, Adelaida
    Adeva, Jorge
    Castillo, Alfredo
    Munoz, Andres
    Peinado, Paloma
    Martinez de Castro, Eva
    Lobo, Miriam
    Granja, Monica
    Maria Rodriguez-Alonso, Rosa
    Fernandez Montes, Ana
    Vera, Ruth
    Gallego, Javier
    Grana, Begona
    Ghanem, Ismael
    Ales, Inmaculada
    Molina, Raquel
    Macarulla, Teresa
    Aranda, Enrique
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Evaluation of Progression-Free Survival as a Surrogate Endpoint for Survival in Chemotherapy and Targeted Agent Metastatic Colorectal Cancer Trials
    Sidhu, Roger
    Rong, Alan
    Dahlberg, Steve
    CLINICAL CANCER RESEARCH, 2013, 19 (05) : 969 - 976
  • [25] Assessment of Progression-free Survival as a Surrogate Endpoint for Overall Survival in Patients With Metastatic Renal Cell Carcinoma
    Negrier, S.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Charbonneau, C.
    Sandin, R.
    Michaelson, M. D.
    Figlin, R. A.
    Motzer, R. J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S163 - S163
  • [26] Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials
    Han, Kelong
    Ren, Melanie
    Wick, Wolfgang
    Abrey, Lauren
    Das, Asha
    Jin, Jin
    Reardon, David A.
    NEURO-ONCOLOGY, 2014, 16 (05) : 696 - 706
  • [27] Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
    Halabi, Susan
    Roy, Akash
    Rydzewska, Larysa
    Guo, Siyuan
    Godolphin, Peter
    Hussain, Maha
    Tangen, Catherine
    Thompson, Ian
    Xie, Wanling
    Carducci, Michael A.
    Smith, Matthew R.
    Morris, Michael J.
    Gravis, Gwenaelle
    Dearnaley, David P.
    Verhagen, Paul
    Goto, Takayuki
    James, Nick
    Buyse, Marc E.
    Tierney, Jayne F.
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (09)
  • [28] Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer
    Hirai, Takehiro
    Nemoto, Asuka
    Ito, Yoshinori
    Matsuura, Masaaki
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (01) : 189 - 198
  • [29] Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer
    Takehiro Hirai
    Asuka Nemoto
    Yoshinori Ito
    Masaaki Matsuura
    Breast Cancer Research and Treatment, 2020, 181 : 189 - 198
  • [30] DISEASE-FREE SURVIVAL (DFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN ADULTS WITH RESECTABLE ESOPHAGEAL OR GASTROESOPHAGEAL JUNCTION CANCER: A CORRELATION META-ANALYSIS
    Leung, L.
    Kurt, M.
    Singh, P.
    Kim, I
    Donnellan, G.
    Kanters, S.
    VALUE IN HEALTH, 2021, 24 : S1 - S1
12345